Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP1.4979 for essential tremor
2024-517987-46-00Phase 2Completed
- Sponsor
- Bioprojet
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in essential tremor (ET) comparing BP1.4979 with Placebo (2 arms). Primary endpoint: Change in TETRAS Performance Subscale total score. Started Jul 2025; status: completed.
02
Drugs
BP-1.4979
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on 2024-517987-46-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517987-46-00.